https://m2.mtmt.hu/ eng 2026-09-22 05:02 JournalArticle 33053578 VALIDATED true Cited By :4 Export Date: 12 February 2024 Correspondence Address: Miklya, I.; Department of Pharmacology and Pharmacotherapy, Nagyvarad ter 4, Hungary; email: miklya.ildiko@med.semmelweis-univ.hu Chemicals/CAS: calphostin C, 121263-19-2; dopamine, 51-61-6, 62-31-7; methamphetamine, 28297-73-6, 51-57-0, 537-46-2, 7632-10-2; n ethylmaleimide, 128-53-0; nomifensine, 24526-64-5; phorbol 13 acetate 12 myristate, 16561-29-8; protein kinase C, 141436-78-4; protein kinase C theta; serine threonine protein kinase D2; tetrabenazine, 58-46-8; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Methamphetamine; Receptors, G-Protein-Coupled Funding details: Nemzeti Kutatási, Fejlesztési és Innovaciós Alap, NKFIA Funding text 1: The authors declare this work was supported by the Fujimoto Pharmaceutical Corporation, Osaka, Japan. Funding text 2: TKP2021-EGA-25 has been implemented with the support provided by the Ministry of Innovation and Technology of Hungary from the National Research, Development, and Innovation Fund, financed under the TKP2021-EGA-25 funding scheme. The authors would like to thank Fujimoto Pharmaceutical Corporation, Osaka, Japan, for supporting this research. 0 false 2026-05-22T02:22:31.586+0000 2025-07-01T19:17:00.175+0000 2022-08-16T15:45:32.419+0000 true 10026589 Tichy Rita /api/admin/10026589 Admin Rita Tichy (SE_KK_Admin5_TR, admin) true 10026589 2025-08-13T11:26:49.961+0000 2022-08-25T09:27:25.667+0000 true 10080205 Szalóky-Siki Ágnes /api/admin/10080205 Admin Ágnes Szalóky-Siki (SE_KK_Admin5_SZSA, admin) true true false true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Article (Journal Article) 101 true 10000059 true 1 /api/category/1 Category Scientific true 1 Harsing, Laszlo true true /api/journal/10003252 REVIEWED INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 true false 10003252 false 10003252 true 1661-6596 1422-0067 Journal FOREIGN 23 15 8543 8543 36 2022 The trace amine-associated receptor 1 (TAAR1) is a Gs protein-coupled, intracellularly located metabotropic receptor. Trace and classic amines, amphetamines, act as agonists on TAAR1; they activate downstream signal transduction influencing neurotransmitter release via intracellular phosphorylation. Our aim was to check the effect of the catecholaminergic activity enhancer compound ((−)BPAP, (R)-(−)-1-(benzofuran-2-yl)-2-propylaminopentane) on neurotransmitter release via the TAAR1 signaling. Rat striatal slices were prepared and the resting and electrical stimulation-evoked [3H]dopamine release was measured. The releaser (±)methamphetamine evoked non-vesicular [3H]dopamine release in a TAAR1-dependent manner, whereas (−)BPAP potentiated [3H]dopamine release with vesicular origin via TAAR1 mediation. (−)BPAP did not induce non-vesicular [3H]dopamine release. N-Ethylmaleimide, which inhibits SNARE core complex disassembly, potentiated the stimulatory effect of (−)BPAP on vesicular [3H]dopamine release. Subsequent analyses indicated that the dopamine-release stimulatory effect of (−)BPAP was due to an increase in PKC-mediated phosphorylation. We have hypothesized that there are two binding sites present on TAAR1, one for the releaser and one for the enhancer compounds, and they activate different PKC-mediated phosphorylation leading to the evoking of non-vesicular and vesicular dopamine release. (−)BPAP also increased VMAT2 operation enforcing vesicular [3H]dopamine accumulation and release. Vesicular dopamine release promoted by TAAR1 evokes activation of D2 dopamine autoreceptor-mediated presynaptic feedback inhibition. In conclusion, TAAR1 possesses a triggering role in both non-vesicular and vesicular dopamine release, and the mechanism of action of (−)BPAP is linked to the activation of TAAR1 and the signal transduction attached. Funding 2016940 /api/funding/2016940 (TKP2021-EGA-25) false true true 2022 true true true false true false GOLD 2026-05-22 true https://doi.org/10.3390/ijms23158543 10 0 10 8 2 10 10 9 10 10 10 8 8 8 2 0 10 8 10 8 0 14 14 Folyóiratcikk Journal Article 24 10 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2023 0 4 3 4 3 2024 0 1 1 1 1 2025 0 4 3 4 3 2026 0 1 1 1 1 D1 false 10011448 false false false 2022-08-24T09:27:25.275+0000 Akadémikus bibliográfia; Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 3 15 2 3 0 true Language 10002 /api/language/10002 English Angol English true 2 true PersonAuthorship 103144354 /api/authorship/103144354 Harsing, Laszlo [Hársing, László Gábor (Farmakológia), author] Department of Pharmacology and Pharmacotherapy (SU / FM / I) 1 0.333 true false false Author 10000022 /api/author/10000022 László Gábor Hársing (Farmakológia) Hársing László Gábor true 10000022 true Harsing Laszlo true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 103144355 /api/authorship/103144355 Knoll, Joseph [Knoll, József (Farmakológia), author] Department of Pharmacology and Pharmacotherapy (SU / FM / I) 2 0.333 false false false Author 10000841 /api/author/10000841 József Knoll (Farmakológia) Knoll József true 10000841 true Knoll Joseph true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 103144356 /api/authorship/103144356 Miklya, Ildiko ✉ [Miklya, Ildikó (Neuropszichofarma...), author] Department of Pharmacology and Pharmacotherapy (SU / FM / I) 3 0.333 false true true Author 10011448 /api/author/10011448 Ildikó Miklya (Neuropszichofarmakológia) Miklya Ildikó true 10011448 true Miklya Ildiko true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true Institute 19040 /api/institute/19040 Bibliografy of Hungarian of Academy of Sciences' academicians [2016-] 0 false false true Akadémikus bibliográfia Bibliografy of Hungarian of Academy of Sciences' academicians true 19040 true PublicationIdentifier 21587319 /api/publicationidentifier/21587319 DOI: 10.3390/ijms23158543 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.3390/ijms23158543 https://doi.org/10.3390/ijms23158543 false true PublicationIdentifier 21614564 /api/publicationidentifier/21614564 WoS: 000839061400001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000839061400001 https://www.webofscience.com/wos/woscc/full-record/000839061400001 true true PublicationIdentifier 21664169 /api/publicationidentifier/21664169 Scopus: 85136342543 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85136342543 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85136342543 true true PublicationIdentifier 21587320 /api/publicationidentifier/21587320 PubMed: 35955676 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 35955676 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35955676&dopt=Abstract false true Classification 12197 /api/classification/12197 Pharmacology, pharmacogenomics, drug discovery and design, drug therapy true true SjrRating 11289558 /api/sjrrating/11289558 sjr:D1 (2022) Scopus - Inorganic Chemistry INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 7 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1604 /api/classificationexternal/1604 Scopus - Inorganic Chemistry true 1604 true D1 DIRECT true true Reference 32916199 /api/reference/32916199 1. DOI: 10.1073/pnas.151105198 1 10.1073/pnas.151105198 false true Reference 32916200 /api/reference/32916200 2. DOI: 10.1124/mol.60.6.1181 2 10.1124/mol.60.6.1181 false true Reference 32916201 /api/reference/32916201 3. DOI: 10.1016/j.pharmthera.2007.06.007 3 10.1016/j.pharmthera.2007.06.007 false true Reference 32916202 /api/reference/32916202 4. DOI: 10.1124/pr.117.015305 4 10.1124/pr.117.015305 false true Reference 32916203 /api/reference/32916203 5. DOI: 10.3389/fnins.2016.00148 5 10.3389/fnins.2016.00148 false true Reference 32916204 /api/reference/32916204 6. DOI: 10.1016/j.bcp.2009.05.031 6 10.1016/j.bcp.2009.05.031 false true Reference 32916205 /api/reference/32916205 7. DOI: 10.1124/jpet.105.084459 7 10.1124/jpet.105.084459 false true Reference 32916206 /api/reference/32916206 8. DOI: 10.1073/pnas.0906522106 8 10.1073/pnas.0906522106 false true Reference 32916207 /api/reference/32916207 9. DOI: 10.1073/pnas.1103029108 9 10.1073/pnas.1103029108 false true Reference 32916208 /api/reference/32916208 10. DOI: 10.1124/jpet.106.116863 10 10.1124/jpet.106.116863 false true Reference 32916209 /api/reference/32916209 11. DOI: 10.1124/jpet.109.153775 11 10.1124/jpet.109.153775 false true Reference 32916210 /api/reference/32916210 12. DOI: 10.1111/j.1471-4159.2010.07109.x 12 10.1111/j.1471-4159.2010.07109.x false true Reference 32916211 /api/reference/32916211 13. DOI: 10.1016/j.neuropharm.2014.02.007 13 10.1016/j.neuropharm.2014.02.007 false true Reference 32916212 /api/reference/32916212 14. DOI: 10.1016/j.neuropharm.2003.11.031 14 10.1016/j.neuropharm.2003.11.031 false true Reference 32916213 /api/reference/32916213 15. DOI: 10.1016/j.ygeno.2004.11.010 15 10.1016/j.ygeno.2004.11.010 false true Reference 32916214 /api/reference/32916214 16. DOI: 10.1016/j.conb.2015.01.001 16 10.1016/j.conb.2015.01.001 false true Reference 32916215 /api/reference/32916215 17. DOI: 10.1007/978-1-4612-5312-9 17 10.1007/978-1-4612-5312-9 false true Reference 32916216 /api/reference/32916216 18. DOI: 10.1111/j.1471-4159.2004.02501.x 18 10.1111/j.1471-4159.2004.02501.x false true Reference 32916217 /api/reference/32916217 19. DOI: 10.1038/sj.bjp.0706948 19 10.1038/sj.bjp.0706948 false true Reference 32916218 /api/reference/32916218 20. Yang 1973: β-Phenethylamine: A specific substrate for type B monoamine oxidase of brain., J. Pharmacol. Exp. Ther., 187, p. 365 20 false true Reference 32916219 /api/reference/32916219 21. DOI: 10.1124/jpet.107.134247 21 10.1124/jpet.107.134247 false true Reference 32916220 /api/reference/32916220 22. DOI: 10.1124/jpet.107.135079 22 10.1124/jpet.107.135079 false true Reference 32916221 /api/reference/32916221 23. DOI: 10.1016/j.ejphar.2018.08.037 23 10.1016/j.ejphar.2018.08.037 false true Reference 32916222 /api/reference/32916222 24. DOI: 10.1002/dta.1578 24 10.1002/dta.1578 false true Reference 32916223 /api/reference/32916223 25. DOI: 10.1038/sj.bjp.0702995 25 10.1038/sj.bjp.0702995 false true Reference 32916224 /api/reference/32916224 26. DOI: 10.1016/S0968-0896(01)00002-5 26 10.1016/S0968-0896(01)00002-5 false true Reference 32916225 /api/reference/32916225 27. DOI: 10.1016/S0024-3205(03)00197-8 27 10.1016/S0024-3205(03)00197-8 false true Reference 32916226 /api/reference/32916226 28. DOI: 10.1016/j.pnpbp.2003.11.016 28 10.1016/j.pnpbp.2003.11.016 false true Reference 32916227 /api/reference/32916227 29. DOI: 10.1016/S0968-0896(00)00341-2 29 10.1016/S0968-0896(00)00341-2 false true Reference 32916228 /api/reference/32916228 30. DOI: 10.1111/j.1527-3458.2001.tb00202.x 30 10.1111/j.1527-3458.2001.tb00202.x false true Reference 32916229 /api/reference/32916229 31. DOI: 10.1016/j.lfs.2016.10.023 31 10.1016/j.lfs.2016.10.023 false true Reference 32916230 /api/reference/32916230 32. DOI: 10.1016/j.lfs.2017.06.010 32 10.1016/j.lfs.2017.06.010 false true Reference 32916231 /api/reference/32916231 33. DOI: 10.1007/s12253-019-00603-6 33 10.1007/s12253-019-00603-6 false true Reference 32916232 /api/reference/32916232 34. Gaszner 2004: The use of the synthetic enhancer substances (−)deprenyl and (−)-BPAP in major depression., Neuropsychopharmacol. Hung., 6, p. 210 34 false true Reference 32916233 /api/reference/32916233 35. DOI: 10.1016/j.bbr.2007.12.016 35 10.1016/j.bbr.2007.12.016 false true Reference 32916234 /api/reference/32916234 36. DOI: 10.1016/j.bbr.2019.112290 36 10.1016/j.bbr.2019.112290 false true Reference 32916235 /api/reference/32916235 37. DOI: 10.1007/b139067 37 10.1007/b139067 false true Reference 32916236 /api/reference/32916236 38. Harsing 2008: Dopamine and the dopaminergic systems of the brain.Handbook of Neurochemistry and Molecular Neurobiology, Neurotransmitter Systems, p. 149 38 false true Reference 32916237 /api/reference/32916237 39. DOI: 10.1159/000468598 39 10.1159/000468598 false true Reference 32916238 /api/reference/32916238 40. DOI: 10.1523/JNEUROSCI.21-16-06338.2001 40 10.1523/JNEUROSCI.21-16-06338.2001 false true Reference 32916239 /api/reference/32916239 41. DOI: 10.1016/0006-2952(74)90344-X 41 10.1016/0006-2952(74)90344-X false true Reference 32916240 /api/reference/32916240 42. DOI: 10.1016/0006-2952(79)90217-X 42 10.1016/0006-2952(79)90217-X false true Reference 32916241 /api/reference/32916241 43. DOI: 10.1074/jbc.C000237200 43 10.1074/jbc.C000237200 false true Reference 32916242 /api/reference/32916242 44. DOI: 10.1016/j.ejphar.2003.08.059 44 10.1016/j.ejphar.2003.08.059 false true Reference 32916243 /api/reference/32916243 45. DOI: 10.1016/S0896-6273(00)80603-0 45 10.1016/S0896-6273(00)80603-0 false true Reference 32916244 /api/reference/32916244 46. DOI: 10.1111/jnc.12371 46 10.1111/jnc.12371 false true Reference 32916245 /api/reference/32916245 47. DOI: 10.1016/j.neuroscience.2013.11.059 47 10.1016/j.neuroscience.2013.11.059 false true Reference 32916246 /api/reference/32916246 48. DOI: 10.1111/j.1749-6632.1990.tb31991.x 48 10.1111/j.1749-6632.1990.tb31991.x false true Reference 32916247 /api/reference/32916247 49. DOI: 10.1016/j.neuron.2004.12.056 49 10.1016/j.neuron.2004.12.056 false true Reference 32916248 /api/reference/32916248 50. DOI: 10.1016/j.neuropharm.2015.07.028 50 10.1016/j.neuropharm.2015.07.028 false true Reference 32916249 /api/reference/32916249 51. DOI: 10.1016/j.pharep.2013.11.003 51 10.1016/j.pharep.2013.11.003 false true Reference 32916250 /api/reference/32916250 52. DOI: 10.1016/S0006-8993(98)00040-7 52 10.1016/S0006-8993(98)00040-7 false true Reference 32916251 /api/reference/32916251 53. DOI: 10.1124/jpet.106.103622 53 10.1124/jpet.106.103622 false true Reference 32916252 /api/reference/32916252 54. DOI: 10.1016/j.bmcl.2010.12.075 54 10.1016/j.bmcl.2010.12.075 false true Reference 32916253 /api/reference/32916253 55. DOI: 10.1124/jpet.106.117382 55 10.1124/jpet.106.117382 false true Reference 32916254 /api/reference/32916254 56. DOI: 10.1124/jpet.111.191056 56 10.1124/jpet.111.191056 false true Reference 32916255 /api/reference/32916255 57. DOI: 10.1016/j.ejphar.2003.09.044 57 10.1016/j.ejphar.2003.09.044 false true Reference 32916256 /api/reference/32916256 58. DOI: 10.1016/j.pneurobio.2005.04.003 58 10.1016/j.pneurobio.2005.04.003 false true Reference 32916257 /api/reference/32916257 59. DOI: 10.1016/j.pharmthera.2004.10.012 59 10.1016/j.pharmthera.2004.10.012 false true Reference 32916258 /api/reference/32916258 60. DOI: 10.1016/0028-3908(92)90049-U 60 10.1016/0028-3908(92)90049-U false true Reference 32916259 /api/reference/32916259 61. DOI: 10.1101/cshperspect.a005637 61 10.1101/cshperspect.a005637 false true Reference 32916260 /api/reference/32916260 62. DOI: 10.1016/S0896-6273(00)80418-3 62 10.1016/S0896-6273(00)80418-3 false true Reference 32916261 /api/reference/32916261 63. DOI: 10.1124/pr.114.010397 63 10.1124/pr.114.010397 false true Reference 32916262 /api/reference/32916262 64. Scherman 1984: Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding., Mol. Pharmacol., 25, p. 113 64 false true Reference 32916263 /api/reference/32916263 65. DOI: 10.1016/S0197-0186(00)00076-0 65 10.1016/S0197-0186(00)00076-0 false true Reference 32916264 /api/reference/32916264 66. DOI: 10.1523/JNEUROSCI.21-16-05916.2001 66 10.1523/JNEUROSCI.21-16-05916.2001 false true Reference 32916265 /api/reference/32916265 67. Raiteri 1979: Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine., J. Pharmacol. Exp. Ther., 208, p. 195 67 false true Reference 32916266 /api/reference/32916266 68. DOI: 10.1016/0304-3940(91)90869-U 68 10.1016/0304-3940(91)90869-U false true Reference 32916267 /api/reference/32916267 69. Kantor 2001: Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells., J. Pharmacol. Exp. Ther., 297, p. 1016 69 false true Reference 32916268 /api/reference/32916268 70. DOI: 10.1371/journal.pbio.0020078 70 10.1371/journal.pbio.0020078 false true Reference 32916269 /api/reference/32916269 71. DOI: 10.1523/JNEUROSCI.18-06-01979.1998 71 10.1523/JNEUROSCI.18-06-01979.1998 false true Reference 32916270 /api/reference/32916270 72. DOI: 10.1523/JNEUROSCI.2136-12.2013 72 10.1523/JNEUROSCI.2136-12.2013 false true Reference 32916271 /api/reference/32916271 73. DOI: 10.1111/jnc.12197 73 10.1111/jnc.12197 false true Reference 32916272 /api/reference/32916272 74. DOI: 10.1016/j.neuron.2011.02.010 74 10.1016/j.neuron.2011.02.010 false true Reference 32916273 /api/reference/32916273 75. DOI: 10.1038/ncomms10652 75 10.1038/ncomms10652 false true Reference 32916274 /api/reference/32916274 76. DOI: 10.1074/jbc.M005869200 76 10.1074/jbc.M005869200 false true Reference 32916275 /api/reference/32916275 77. DOI: 10.1523/JNEUROSCI.0285-05.2005 77 10.1523/JNEUROSCI.0285-05.2005 false true Reference 32916276 /api/reference/32916276 78. DOI: 10.1124/jpet.107.132647 78 10.1124/jpet.107.132647 false true Reference 32916277 /api/reference/32916277 79. DOI: 10.1152/physrev.1989.69.3.864 79 10.1152/physrev.1989.69.3.864 false true Reference 32916278 /api/reference/32916278 80. DOI: 10.1111/j.1471-4159.1966.tb09873.x 80 10.1111/j.1471-4159.1966.tb09873.x false true Reference 32916279 /api/reference/32916279 81. DOI: 10.1111/j.1471-4159.1992.tb08874.x 81 10.1111/j.1471-4159.1992.tb08874.x false true /api/publication/33053578 Harsing Laszlo et al. Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum. (2022) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 23 15<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10000022"><a href="/gui2/?type=authors&mode=browse&sel=10000022" target="_blank">Harsing Laszlo (<span class="authorship-author-name">Hársing László Gábor</span> <span class="authorAux-mtmt"> Farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/Department of Pharmacology and Pharmacotherapy</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10000841"><a href="/gui2/?type=authors&mode=browse&sel=10000841" target="_blank">Knoll Joseph (<span class="authorship-author-name">Knoll József</span> <span class="authorAux-mtmt"> Farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/Department of Pharmacology and Pharmacotherapy</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10011448"><a href="/gui2/?type=authors&mode=browse&sel=10011448" target="_blank">Miklya Ildiko ✉ (<span class="authorship-author-name">Miklya Ildikó</span> <span class="authorAux-mtmt"> Neuropszichofarmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/Department of Pharmacology and Pharmacotherapy</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;33053578" target="_blank">Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum</a></div> <div> <span class="journal-title">INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1661-6596">1661-6596</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1422-0067">1422-0067</a>)</span>: <span class="journal-volume">23</span> <span class="journal-issue">15</span> <span class="page"> Paper 8543. 36 p. </span> <span class="year">(2022)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Language: English | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.3390/ijms23158543" target="_blank" href="https://doi.org/10.3390/ijms23158543"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000839061400001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000839061400001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85136342543" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85136342543"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="35955676" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35955676&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Journal subject: Scopus - Inorganic Chemistry&nbsp;&nbsp;&nbsp;Rank:&nbsp;D1</div> <div class="journal-subject">Journal subject: Scopus - Spectroscopy&nbsp;&nbsp;&nbsp;Rank:&nbsp;D1</div> <div class="journal-subject">Journal subject: Scopus - Computer Science Applications&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Organic Chemistry&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Physical and Theoretical Chemistry&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q1</div> <div class="journal-subject">Journal subject: Scopus - Catalysis&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q2</div> <div class="journal-subject">Journal subject: Scopus - Molecular Biology&nbsp;&nbsp;&nbsp;Rank:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="" class="citingPub-count">Citing papers: 10</span> | Independent citation: 8 | Self citation: 2 | Unknown citation: 0 | Number of citations in WoS: 9 | Number of citations in Scopus:&nbsp;10 | WoS/Scopus assigned:&nbsp;10 | Number of citations with DOI:&nbsp;10 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;33053578&sort=publishedYear,desc&sort=title"> Number of cited publications: 14 </a> </div> <div class="mtid"><span class="long-pub-mtid">Publication: 33053578</span> | <span class="status-data status-VALIDATED"> Validated </span> Core Citing | <span class="type-subtype">Journal Article ( Article ) </span> | <span class="pub-category">Scientific</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="special-affiliations"> Special affiliation: Bibliografy of Hungarian of Academy of Sciences' academicians </div> <div class="funder"> (TKP2021-EGA-25) </div> <div class="lastModified">Last Modified: 2025.07.01. 21:17 Gusztáv Ladányi (MTMT API user, admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Cited By :4 Export Date: 12 February 2024 Correspondence Address: Miklya, I.; Department of Pharmacology and Pharmacotherapy, Nagyvarad ter 4, Hungary; email: miklya.ildiko@med.semmelweis-univ.hu Chemicals/CAS: calphostin C, 121263-19-2; dopamine, 51-61-6, 62-31-7; methamphetamine, 28297-73-6, 51-57-0, 537-46-2, 7632-10-2; ...</pre> </div></div>